Reports By Brokerage: Axis Securities
Navin Fluorine Has Strong Growth Chemistry: Axis Securities | |
Company: | Navin Fluorine |
Brokerage: | Axis Securities |
Date of report: | June 17, 2021 |
Type of Report: | Initiating Coverage |
Recommendation: | Buy |
Upside Potential: | 17% |
Summary: | Strong Growth Chemistry |
Full Report: | Click here to view full post with link to download pdf file |
Tags: |
Reports By Brokerage: Axis Securities
Covid 2.0: Investment Ideas | |
Company: | Model Portfolio |
Brokerage: | Axis Securities |
Date of report: | April 23, 2021 |
Type of Report: | Model Portfolio |
Recommendation: | Buy |
Upside Potential: | 39% |
Summary: | Reduce NIFTY50 target to 16100 but remain cautiously optimistic |
Full Report: | Click here to view full post with link to download pdf file |
Tags: |
Reports By Brokerage: Axis Securities
Axis Top Picks for April 2021 | |
Company: | Model Portfolio |
Brokerage: | Axis Securities |
Date of report: | April 1, 2021 |
Type of Report: | Model Portfolio |
Recommendation: | Buy |
Upside Potential: | 100% |
Summary: | New Fiscal; New Hope! |
Full Report: | Click here to view full post with link to download pdf file |
Tags: |
Reports By Brokerage: Axis Securities
Gland Pharma Initiating Coverage Research Report By Axis Securities | |
Company: | Gland Pharma Ltd |
Brokerage: | Axis Securities |
Date of report: | March 9, 2021 |
Type of Report: | Initiating Coverage |
Recommendation: | Buy |
Upside Potential: | 15% |
Summary: | Well-positioned to Capitalise Fast-growing Generic Injectibles Market |
Full Report: | Click here to view full post with link to download pdf file |
Tags: |
Reports By Brokerage: Axis Securities
NIFTY Target Upgraded To 17,200 + Best 15 Stocks To Buy Now: Axis Securities Report | |
Company: | Model Portfolio |
Brokerage: | Axis Securities |
Date of report: | March 2, 2021 |
Type of Report: | Model Portfolio |
Recommendation: | Buy |
Upside Potential: | 36% |
Summary: | Structural trends intact; Upgrade Nifty Target to 17,200 |
Full Report: | Click here to view full post with link to download pdf file |
Tags: |
Reports By Brokerage: Axis Securities
Top 10 Fundamentally Strong Stocks To Buy Now To Benefit From Stock Market Crash: Axis Securities | |
Company: | Model Portfolio |
Brokerage: | Axis Securities |
Date of report: | February 26, 2021 |
Type of Report: | Model Portfolio |
Recommendation: | Buy |
Upside Potential: | 100% |
Summary: | Opportunities in times of adversity! |
Full Report: | Click here to view full post with link to download pdf file |
Tags: |
Reports By Brokerage: Axis Securities
Buy Camlin Fine Sciences For 46% Upside Gain: Axis Securities | |
Company: | Camlin Fine Sciences |
Brokerage: | Axis Securities |
Date of report: | February 19, 2021 |
Type of Report: | Initiating Coverage |
Recommendation: | Buy |
Upside Potential: | 46% |
Summary: | Strategically Integrated Player |
Full Report: | Click here to view full post with link to download pdf file |
Tags: |
Reports By Brokerage: Axis Securities
Top Stocks To Buy For 2021 By Axis Securities | |
Company: | Model Portfolio |
Brokerage: | Axis Securities |
Date of report: | January 1, 2021 |
Type of Report: | Model Portfolio |
Recommendation: | Buy |
Upside Potential: | 100% |
Summary: | 2021: A year of resuscitation of growth |
Full Report: | Click here to view full post with link to download pdf file |
Tags: |
Reports By Brokerage: Axis Securities
Avenue Supermart Limited (DMART) Research Report By Axis Securities | |
Company: | Avenue Supermart, DMart |
Brokerage: | Axis Securities |
Date of report: | December 22, 2020 |
Type of Report: | Initiating Coverage |
Recommendation: | Buy |
Upside Potential: | 16% |
Summary: | Value Retailing + Execution Finesse = DMART |
Full Report: | Click here to view full post with link to download pdf file |
Tags: |
Reports By Brokerage: Axis Securities
AXIS TOP PICKS: More Growth and More value | |
Company: | Model Portfolio |
Brokerage: | Axis Securities |
Date of report: | December 3, 2020 |
Type of Report: | Model Portfolio |
Recommendation: | Buy |
Upside Potential: | 46% |
Summary: | Growth combined with value is a win-win proposition |
Full Report: | Click here to view full post with link to download pdf file |
Tags: |